- Research article
- Open Access
Involvement of RORγt-overexpressing T cells in the development of autoimmune arthritis in mice
Arthritis Research & Therapyvolume 17, Article number: 105 (2015)
Differentiation of T helper 17 cells is dependent on the expression of transcription retinoid-related orphan receptor gamma t (RORγt). The purpose of our study is to determine the role of RORγt expression in T cells on the development of collagen-induced arthritis (CIA).
CIA was induced in C57BL/6 and T cell-specific RORγt transgenic (RORγt Tg) mice. At day 10 post-1st-immunization, lymph node (LN) cells were cultured with type II collagen (CII), and the expression levels of various cytokines and transcription factors on CD4+ T cells were measured. Total cells or CD4+ cells of draining LN were harvested from each mouse group after CII-immunization and transferred into C57BL/6 mice, and then CIA was induced in recipient mice. The expression levels of RORγt and other surface antigens, and the production of cytokines were analyzed in forkhead box P3 (Foxp3)+ regulatory T (Treg) cells. Foxp3+ Treg cells were analyzed for suppressive activity against proliferation of effector CD4+ T cells. Interlukin (IL)-10 neutralizing antibody was administrated in the course of CIA.
CIA was significantly suppressed in RORγt Tg mice compared with C57BL/6 mice. RORγt expression and IL-17 production were significantly higher in CII-reactive CD4+ T cells from RORγt Tg mice. Arthritis was significantly attenuated in C57BL/6 mice recipient of cells from RORγt Tg mice. Most of Foxp3+ Treg cells expressed RORγt, produced IL-10 but not IL-17, and overexpressed CC chemokine receptor 6 (CCR6) and surface antigens related to the suppressive activity of Foxp3+ Treg cells in RORγt Tg mice. In vitro suppression assay demonstrated significant augmentation of the suppressive capacity of Foxp3+ Treg cells in RORγt Tg mice. CIA was exacerbated in both C57BL/6 mice and RORγt Tg mice by the treatment of anti-IL-10 antibody.
Our results indicated that RORγt overexpression in T cells protected against the development of CIA. The protective effects were mediated, at least in part, through the anti-inflammatory effects including high production of IL-10 of RORγt+Foxp3+ Treg cells.
Rheumatoid arthritis (RA) is a chronic inflammatory disorder characterized by autoimmunity, infiltration of activated inflammatory cells into the joint synovium, synovial hyperplasia, neoangiogenesis, and progressive destruction of the cartilage and bone. This disease affects 1 to 2% of the population worldwide, most commonly middle-aged women. The etiology of RA is unknown but pro-inflammatory cytokines seem to play a central role. Thus, correction of any cytokine imbalance can probably control this disease.
T cells form a large proportion of the inflammatory cells invading the synovial tissue. CD4+ T cells are one of the T cell subsets involved in the RA pathological process. Upon antigenic stimulation and cytokine signaling, naïve CD4+ T cells activate and differentiate into various T helper (Th) subsets . Classically Th cells are divided into Th1 and Th2 subsets according to their cytokine production pattern. Recently, IL-17-producing Th17 cells have been identified and this T cell population appears to play a critical role in the generation of several types of autoimmune arthritis such as glucose-6-phosphate isomerase (GPI)-induced arthritis  and collagen-induced arthritis (CIA) . Moreover, blockade of IL-17 after disease onset prevents cartilage and bone destruction, leading to amelioration of the clinical symptoms of the disease in CIA . Another study identified IL-17 receptor signaling as a critical pathway in turning acute synovitis into chronic destructive arthritis . In RA patients, IL-17 is spontaneously produced by the rheumatoid synovium , and a high percentage of IL-17-positive CD4+ T cells in peripheral blood mononuclear cells have been detected in RA patients compared with healthy control subjects . Therefore, Th17 is considered to be related to the development of RA. Lineage commitment of each Th cell subset from naive CD4+ T cells is dependent on the expression of specific transcription factors induced by specific cytokine environment. Each Th cell-specific transcription factor does not only regulate the expression of effector molecules like cytokines and chemokines specific for each Th cell subset, but also negatively regulates the differentiation of other T cell subsets [8,9].
Differentiation of Th1 and Th2 cells is dependent on the expression of transcription factor T-box transcription factor (T-bet)  and GATA binding protein-3 (GATA-3) , respectively. Similarly, transforming growth factor-β (TGF-β) and IL-6 induce the expression of the transcription factor RORγt, which upregulates the expression of Th-17-specific molecules, IL-17A, IL-17 F, CC chemokine ligand 20 (CCL20), and chemokine receptor CCR6 in mice [12-14]. Recent studies highlighted the importance of Th cell-specific transcription factors in the development of autoimmune arthritis. For example, in mice models of autoimmune arthritis, GATA-3 expression protects against joint inflammation and destruction by reducing the differentiation of Th17 cells . Furthermore, we reported previously that T-bet expression regulates the development of autoimmune arthritis by suppression of antigen reactive Th17 cells differentiation via interferon (IFN)γ-independent suppression of RORγt expression . In RA patients, CD4+ T cells overexpress IL-17 and RORC (encoding RORγt), compared with healthy control subjects . Thus, more work is needed to determine whether RORγt expression and dominant differentiation of Th17 play a role in the development of autoimmune arthritis.
Recently, Yoh et al.  reported that the T cells of RORγt transgenic (RORγt Tg) mice under the control of CD2 promoter express high levels of RORγt and exhibit a dominant Th17 differentiation pattern . In the present study, CIA was induced in both RORγt Tg mice and C57BL/6 mice. The results showed significant protection of RORγt Tg mice against experimentally induced CIA compared with C57BL/6 mice. Furthermore, although RORγt expression and IL-17 production in type II collagen (CII)-reactive CD4+ T cells were significantly higher in RORγt Tg mice, arthritis was significantly attenuated in C57BL/6 mice recipients of cells from immunized RORγt Tg mice in adoptive transfer of draining lymph node (LN) cells or recipients of CD4+ cells. Foxp3+ Treg cells overexpressed RORγt and CCR6, produced IL-10 but not IL-17, and preferentially infiltrated into the joints of RORγt Tg mice, compared with C57BL/6 mice, after the induction of CIA. In vitro suppression assay demonstrated that the suppressive activity of Foxp3+ Treg cells was significantly augmented in RORγt Tg mice compared with C57BL/6 mice. CIA was significantly exacerbated in RORγt Tg mice by the administration of neutralizing antibody of IL-10. Our results suggest that the inhibition of arthritis in RORγt Tg mice was mediated by suppressor cell subsets, including IL-10 producing CCR6+RORγt+Foxp3+ Treg cells.
Age- and sex-matched C57BL/6 mice and C57BL/6 CD2- RORγt Tg mice (age 6 to 10 weeks) were used in our experiments. RORγt Tg mice were prepared by backcrossing mice on the C57BL/6 background. For the isolation of Treg cells, RORγt Tg and C57BL/6 mice were crossed with knockin mice with Foxp3-IRES-green fluorescent protein (GFP) (C57BL/6-Foxp3GFP and RORγt Tg-Foxp3GFP mice) provided by B Malissen (Université de la Méditerranée, Marseille, France). All mice were maintained under specific pathogen-free conditions. All experiments described in this report were performed according to the Guide for the Care and Use of Laboratory Animals at the University of Tsukuba, and were approved by the Animal Ethics Review Committee of the University of Tsukuba.
Induction of collagen-induced arthritis
Native chicken CII was obtained from Sigma-Aldrich (St Louis, MO, USA). CII was dissolved in 0.01 M acetic acid and emulsified in complete Freund’s adjuvant (CFA). CFA was prepared by mixing 5 mg heat-killed Mycobacterium tuberculosis (H37Ra; Difco Laboratories, Detroit, MI, USA) and 1 mL incomplete Freund’s adjuvant (Sigma-Aldrich). Mice were immunized intradermally at the base of the tail with 200 μg CII in CFA on days 0 and 21. Arthritis was evaluated visually, and changes in each paw were scored on a scale of 0 to 3 as follows; 0 = normal, 1 = slight swelling and/or erythema, 2 = pronounced swelling, 3 = ankylosis. The score was summed for each limb (maximum score = 12). For histological assessment, mice were sacrificed at day 42 post first CII immunization, and both hind limbs were removed. After fixation and decalcification, the joints were cut into sections and stained with hematoxylin and eosin. Quantification of histological changes was carried out by two independent and blinded observers, and a histological score was assigned to each joint based on the degree of inflammation and erosion, as described previously [16,19]. In the experiment of IL-10 neutralization in the course of CIA, 100 μg of anti-IL-10 antibody (JES5-16E3; BioLegend, San Diego, CA, USA) or isotype control antibody (RTK4530; BioLegend) was administrated intraperitoneally every 2 days from day 22 to 30 post first CII immunization.
Inguinal lymph nodes were collected as draining LNs, and used for the experiments. CD4+ cells in draining LNs and spleen were isolated by positive selection using a magnetic-activated cell sorting (MACS) system with anti-CD4 mAb (Miltenyi Biotec, Bergisch Gladbach, Germany). CXC chemokine receptor 5+ (CXCR5) follicular helper T (Tfh) cells were isolated with Moflo cell sorter (DakoCytomation, Glostrup, Denmark) from MACS-isolated CD4+ T cells. For the isolation of Foxp3+ Treg cells and Foxp3− non-Treg cells, CD4+GFP+ and CD4+GFP− cells were further purified using a Moflo cell sorter from MACS-isolated CD4+ T cells in C57BL/6-Foxp3GFP and RORγt Tg-Foxp3GFP mice. The isolated cells were used for the experiment of adoptive cell transfer and quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) (see below).
Adoptive cell transfer experiment
All cells of draining LN and CD4+ cells were harvested from C57BL/6 mice and RORγt Tg mice at day 10 post first CII immunization. Cells were resuspended in PBS, and 1 × 107 cells from the draining LNs or 2 × 106 of CD4+ cells were injected intravenously into C57BL/6 mice at day 10 post first CII immunization. Recipient mice were immunized with CII in CFA intradermally on day 11 after the cell transfer. Arthritis was evaluated visually as described above.
Total RNA was prepared from Tfh cells isolated from draining LNs on day 10 post first CII immunization with RNeasy Plus Micro (QIAGEN, Venlo, Netherlands) according to the instructions provided by the manufacturer. cDNA was obtained by reverse transcription with a commercially available kit (TaKaRa Bio, Otsu, Japan). A TaqMan Assay-on-Demand gene expression product was used for real-time PCR (Applied Biosystems, Foster City, CA, USA). The expression levels of IL21and Bcl6 were normalized relative to the expression of GAPDH. Analysis was performed with ABI Prism 7500 apparatus (Applied Biosystems).
Draining LN cells were harvested from each mouse at day 10 post first CII immunization. Single cell suspension was prepared, and LN cells (4 × 105 cells/well on a 96-well round-bottom plate) were cultured in Roswell Park Memorial Institute (RPMI) 1640 medium (Sigma-Aldrich) containing 10% FBS, 100 units/mL of penicillin, 100 μg/mL of streptomycin, and 50 μM 2-mercaptoethanol. The LN cells were cultured in the presence of 100 μg/mL denatured chicken CII for 72 h and analyzed for CII-reactive cytokine production. Furthermore, CD4+GFP+ were stimulated with Dynabeads Mouse T-activator CD3/CD28 (Invitrogen, Carlsbad, CA, USA) (1 bead/cell) in round-bottomed 96-well dishes for 96 h and the amount of IL-10 produced by Foxp3+ Treg cells was measured.
Cell migration was evaluated using a 24-well, 3-μm pore-size Transwell system (Corning, Lowell, MA, USA). Briefly, 5 × 105 or 2.5 × 105 of CD4+ cells isolated from draining LN cells were placed on the top of the Transwell, while CCL20 was added to the bottom of the Transwell system with or without 10 μg/mL of anti-IL-10 mAb or isotype control antibody. After 4 h of incubation at 37°C, the number of cells that migrated into the lower well was counted by flow cytometry. Foxp3 expression in the isolated CD4+ cells was also analyzed by flow cytometry before and after the migration.
For flow cytometry, the cell surface was stained with the following antibodies specific for mouse proteins: anti-CD4 (RM4-5 or GK1.5), anti-CD3 (145-2C11), anti-programmed cell death-1 (29 F.1A12), anti-inducible T-cell co-stimulator (ICOS) (C398.4A), anti-CC chemokine receptor 6 (CCR6) (29–2 L17), anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA4) (UC10-4B9), anti-glucocorticoid-induced tumor necrosis factor receptor (GITR) (DTA-1; all from BioLegend) and anti-CXCR5 CXCR5 (2G8; BD PharMingen, San Diego, CA, USA). For intracellular cytokine staining, cells were cultured with or without CII for 72 h, and GolgiStop (BD PharMingen) was added during the last 4 h of each culture. The cell surface was stained and then permeabilized with Cytofix/Cytoperm solution (BD PharMingen). This was followed by intracellular cytokine staining with anti-IL-17A (TC11-18H10; BD PharMingen), anti-IFNγ (XMG1.2; BioLegend), and anti-IL-10 antibodies (JES5-16ES; BioLegend). Mouse Regulatory T Cell Staining Kit (eBioscience, San Diego, CA, USA) was used to stain the transcription factors with anti-Foxp3 (MF-14; Biolegend), anti-T-bet (eBio4B10) and anti-RORγt antibodies (AFKJS-9; both from eBioscience). Annexin V (BioLegend) and propidium iodide (PI) (BioLegend) are used for the detection of apoptotic cells. Data were acquired on a FACSCalibur flow cytometer (Becton Dickinson, Mountain View, CA, USA), and analyzed with FlowJo software (Tree Star, Ashland, OR, USA).
Analysis of cytokine profiles
The supernatants were collected after the cells were cultured with or without CII for 72 h and the levels of IL-17, IFNγ, and IL-10 were analyzed by ELISA using the Quantikine ELISA kit (R&D Systems, Minneapolis, MN, USA).
Measurement of collagen-specific IgG titers
Fifty-six days post first CII immunization, serum was collected, then diluted 1:4,000 in blocking solution containing 1% bovine serum albumin (Wako Pure Chemical Industries, Osaka, Japan) in PBS. Collagen-specific total IgG, IgG1, IgG2a, IgG2b, and IgG3 titers were measured by coated 10 μg/mL of CII in PBS on 96-well plates (Nunc Maxisorp; Nalge Nunc International, Roskilde, Denmark). The optical density was read at 450 nm using a microplate reader.
In vitro suppression assay and Treg culture
Responder cells (CD4+CD25−GFP−) were labelled with 5 μM carboxyfluorescein diacetate succinimidyl ester (CFSE, Invitrogen), then cultured with or without unlabeled Treg cells (CD4+GFP+) at the indicated ratio for 96 h in the presence of Dynabeads Mouse T-activator CD3/CD28 (1 bead/cell) in round-bottomed 96-well dishes. The proliferation inhibition rate on the responder was calculated as: (1-(CFSE percentage Treg plus responder cells co-culture / responder cells alone)) X 100%.
Data are expressed at mean ± standard error of the mean (SEM). Differences between groups were examined for statistical significance using Student’s t-test. P-values <0.05 were considered significant.
Suppression of CIA in RORγt Tg mice
To evaluate the effects of T cell-specific RORγt expression on the development of arthritis, we compared the severity of CIA in RORγt Tg mice and C57BL/6 mice. The incidence of arthritis in RORγt Tg mice was markedly suppressed compared with C57BL/6 mice (Figure 1A). Similarly, the arthritis score was also markedly lower in RORγt Tg than C57BL/6 mice (Figure 1B). Histological analysis of arthritic joints showed widespread infiltration of inflammatory cells and synovial hypertrophy throughout joint tissues of C57BL/6 mice, but not those of RORγt Tg mice (Figure 1C). Furthermore, analysis of joint inflammation and erosion scores showed significant suppression of inflammation and destruction in RORγt Tg mice compared with C57BL/6 mice (Figure 1C). These results indicate that RORγt Tg-expressing T cells suppressed the development of CIA.
Overexpression of RORγt modulates differentiation of CII-reactive CD4+ T cells
To determine the effects of RORγt overexpression on CII-reactive cytokine production, we analyzed draining LN cells harvested at day 10 post first CII immunization. These cells were stimulated with CII in vitro before measurement of cytokine levels in supernatants by ELISA. The level of IL-17 was significantly higher in RORγt Tg mice than in C57BL/6 mice, whereas that of IFNγ was comparable in the two groups (Figure 2A). Fluorescence-activated cell sorting (FACS) analysis of cytokine expression on CD4+ T cells also showed no significant difference in IFNγ production from CII-reactive CD4+ T cells between the two groups of mice (Figure 2B). The same analysis showed a significantly higher IL-17 production by CII-reactive CD4+ T cells of RORγt Tg mice compared with C57BL/6 mice (Figure 2B). We measured the expression of transcription factors critical for differentiation of each CD4+ T cells subset. The mean fluorescence intensity (MFI) of RORγt in CII-reactive CD4+ T cells was significantly higher in RORγt Tg mice than C57BL/6 mice (Figure 2C), but there was no difference in T-bet expression between C57BL/6 and RORγt Tg mice (Figure 2C). We also measured IL-10 production by CII-reactive CD4+ T cells by ELISA and FACS. There was no significant difference in the level of IL-10 between the two groups of mice (Figure 2D), and IL-10 production by CII-reactive CD4+ T cells was almost undetectable with FACS analysis in both mice (Figure 2E). Finally, we examined whether overexpression of RORγt in T cells increases apoptosis in these cells. FACS analysis of apoptotic cells stained with PI and annexin V showed that there was no significant difference between the two groups of mice in the percentage of apoptotic cells in CD4+ T cells cultured with CII in vitro (Figure 2F). These results indicate that overexpression of RORγt induced higher IL-17 production from CII-reactive CD4+ T cells, but had no effect on Th1 differentiation and CII-reactive cytokine production other than IL-17,
Suppression of anti-CII antibody formation
We examined CII-specific IgG production in RORγt Tg mice, because CII-specific IgG level is known to correlate with the development of CIA . Sera were collected at day 56 post first CII immunization, and the levels of CII-specific total IgG, IgG1, IgG2a, IgG2b, and IgG3 were measured by ELISA. Serum CII-specific total IgG was significantly lower in RORγt Tg mice than C57BL/6 mice (P <0.05, Figure 3A), but there was no significant difference in CII-specific IgG1, IgG2a, IgG2b and IgG3 (Figure 3B).
The next experiment examined whether the expression of RORγt affected the differentiation and function of T follicular helper (Tfh) cells. For this purpose, we measured the expression of CXCR5, programmed death-1 (PD-1), and inducible T-cell co-stimulator (ICOS), a marker of Tfh cells, by FACS analysis of CD4+ cells in draining LNs, the expression of B cell lymphoma 6 (Bcl-6), a master transcription factor of Tfh cell differentiation, and the expression of IL-21 in Tfh cells. The expression of Bcl-6 and IL-21 were conducted at day 10 post first CII immunization by real-time PCR using CXCR5+CD4+ Tfh cells from draining LNs sorted by FACS. The FACS analysis showed significantly higher expression of CXCR5 in CD4+ T cells in RORγt Tg mice than C57BL/6 mice (Figure 3C). In addition, ICOS+PD-1+ cells in CXCR5+CD4+ cells was significantly increased in RORγt Tg mice compared with C57BL/6 mice (Figure 3D). On the other hand, the expression level of Bcl-6 was significantly lower on CXCR5+CD4+ Tfh cells of RORγt Tg mice than that of C57BL/6 mice, and the expression levels of IL-21 on CXCR5+CD4+ Tfh cells also tended to be reduced in RORγt Tg compared with C57BL/6 mice (Figure 3E), suggesting the possibility that the differentiation and the function of Tfh cells is suppressed in RORγt Tg mice. These results indicate that suppression of CIA might be related to decreased anti-CII antibody formation caused by the dysfunction of Tfh cells in RORγt Tg mice.
Transfer of T cells from RORγt Tg mice suppresses CIA in immunized C57BL/6 mice
To determine whether the suppressor cells regulate the development of arthritis in RORγt Tg mice, cells from draining LN from immunized C57BL/6 mice or RORγt Tg mice were adoptively transferred into immunized C57BL/6 mice, followed by induction of CIA. Interestingly, arthritis was significantly suppressed in mice recipient of cells from RORγt Tg mice but not those from C57BL/6 mice (Figure 4A). To identify the effectual cells, only CD4+ cells isolated from draining LN of C57BL/6 mice or RORγt Tg mice were adoptively transferred into immunized C57BL/6 mice. Arthritis was also suppressed in mice recipient of CD4+ cells isolated from RORγt Tg mice only, but not from C57BL/6 mice (Figure 4B). These results suggest that CD4+ T cells inhibit the development of autoimmune arthritis in RORγt Tg mice.
RORγt overexpression augments the suppressive function of Foxp3+ Treg cells
Foxp3-expressing CD4+ T cells are known to suppress T cell-mediated immune reaction . In the next series of experiments, the expression of Foxp3 in CD4+ T cells was investigated by intracellular staining using LN cells harvested at day 10 post first CII immunization. Although there was no significant difference in Foxp3 expression in CD4+ T cells between RORγt Tg mice and C57BL/6 mice, higher expression of RORγt in Foxp3+ Treg cells was noted in RORγt Tg mice compared with C57BL/6 mice (Figure 5A, B).
To evaluate whether RORγt+ Foxp3+ Treg cells of RORγt Tg mice retain their stability and suppressive capacity, we analyzed the production of IL-17 and the expression of molecules known to be related to Foxp3+ Treg cell function. The FACS analysis of CD4+ T cells stimulated with CII in vitro showed IL-17 was produced only by Foxp3− non-Treg cells in RORγt Tg mice (Figure 5C). The expression of CD25 (Figure 5D), which is associated with the stability of Foxp3 expression , was not significantly different between C57BL/6 and RORγt Tg mice. Although there was no difference in the expression of CTLA4, that of the co-inhibitory molecule, glucocorticoid-induced tumor necrosis factor receptor (GITR) was significantly higher in RORγt Tg than C57BL/6 mice (Figure 5E), suggesting that stability and suppressive capacity was not affected with overexpression of RORγt in Foxp3+ Treg cells.
To provide an answer to the question of whether Foxp3+ cells can suppress effector cell proliferation in vitro, we compared the ability of isolated CD4+GFP+ cells from C57BL/6-Foxp3GFP and RORγt-Foxp3GFP reporter mice to inhibit the proliferation of CD4+CD25−GFP− cells from C57BL/6-Foxp3GFP mice in vitro. Interestingly, the suppressive capacity of CD4+ GFP+ Treg cells was significantly enhanced in RORγt Tg Foxp3GFP mice compared with C57BL/6-Foxp3GFP reporter mice (Figure 5F), and CD4+GFP+ cells isolated from RORγt Tg Foxp3GFP mice produced a larger amount of IL-10 than C57BL/6-Foxp3GFP mice (Figure 5G). These results indicate that overexpression of RORγt seems to enhance the suppressive function of Foxp3+ Treg cells in RORγt Tg mice.
RORγt overexpression enhances the chemotactic activity of Foxp3+ Treg cells
Because CCR6 expression is positively regulated by RORγt and contributes to the recruitment of cells to the inflamed joints , we analyzed CCR6 expression on CD4+ T cells after CII immunization. CCR6 expression on CD4+ T cells was significantly higher in RORγt Tg than C57BL/6 mice (Figure 6A, P <0.01). Interestingly, the highest expression of CCR6 was observed in Foxp3+CD4+ Treg cells in RORγt Tg mice compared with Foxp3+CD4+ Treg cells in C57BL/6 mice and Foxp3− non-Treg cells in RORγt Tg mice (Figure 6B).
To determine the chemotactic activity of CD4+ T cells to CCL20, the in vitro migration assay was performed using CCR6+ cells. More CD4+ cells migrated in response to CCL20 in RORγt Tg than C57BL/6 mice (Figure 6C). The migrating CD4+ T cells of RORγt Tg mice were enriched for Foxp3+ T cells (Figure 6D). In another in vivo experiment on mice, CIA was induced in both C57BL/6-Foxp3GFP and RORγt Tg-Foxp3GFP reporter mice, and the expression levels of CCR6 and GFP in CD4+ T cells infiltrating the joints were analyzed by flow cytometry. Similar to the results of in vitro migration assay, more CCR6+GFP+ Treg cells migrated into the joints of RORγt Tg-Foxp3GFP reporter mice than C57BL/6-Foxp3GFP reporter mice (Figure 6E). Considered together, these findings suggest that overexpression of RORγt induced CCR6 expression in Foxp3+ Treg cells and that the latter cells are enriched in the inflamed joints of RORγt Tg mice.
Neutralization of IL-10 exacerbates CIA in RORγt Tg mice
To clarify whether the suppression of CIA is related to IL-10, we administrated anti-IL-10 monoclonal antibody (mAb) to neutralize IL-10 in the course of CIA. The severity of arthritis was significantly exacerbated in both C57BL/6 mice and RORγt Tg mice administrated with anti-IL-10 mAb compared with the mice with isotype control antibody, respectively (Figure 7A). However, suppression of CIA was not completely cancelled in RORγt Tg mice with the administration of anti-IL-10 mAb, although there was no statistically significant difference between C57BL/6 mice and RORγt Tg mice treated by anti-IL-10 mAb (Figure 7A). We also examined the effect of IL-10 neutralization on the chemotactic activity of CD4+ T cells isolated from draining LNs at day 10 post first CII immunization in vitro. There was no significant difference in the migration of CD4+ T cells in response to CCL20 by the addition of anti-IL-10 mAb in both two groups of mice (Figure 7B). These data indicated that IL-10 is related to the inhibition of the development of CIA in RORγt Tg mice.
The transcription factor RORγt is a master regulator of the differentiation of Th17 cells and expression of Th17 cytokines; IL-17A, IL-17 F, IL-22 and IL-21 . Previous studies indicate that both IL-17 and Th17 cells seem to be involved in the pathogenesis of rheumatoid arthritis and animal model of autoimmune arthritis [3-7,17]. We have previously reported that the development of murine autoimmune arthritis is suppressed by the overexpression of T-bet, a master regulator of differentiation of Th1 cells, and suggested that Th17 cells differentiation is inhibited by T-bet through downregulation of RORγt . To elucidate the effects of RORγt on T cell function in autoimmune arthritis, we used RORγt Tg mice under the control of CD2 promoter. In RORγt Tg mice, most T cells were considered Th17 cells based on the high expression level of RORγt and production of high amounts of IL-17, compared to comparable levels of IFNγ and IL-4 found in WT mice . Contrary to our expectation, overexpression of RORγt provided protection against the development of autoimmune arthritis in mice. While the exact mechanism of this protection is unknown, we propose three scenarios: imbalance in Th1/Th17 cell ratio, low anti-CII antibody formation, and CD4+ Treg cell hyperfunction.
Does imbalance in the Th17/Th1 cell ratio play a pathogenic role in experimentally induced CIA in RORγt Tg mice? Previous studies reported that Th1 cells have anti-inflammatory properties in experimental arthritis [16,23,24]. Accordingly, we focused in this study on cytokine production and transcription factor expression in CII reactive CD4+ T cells. The results showed significantly high IL-17 production and RORγt expression in CII-reactive T cells of RORγt Tg mice, but no differences in IFNγ production and T-bet expression, compared with C57BL/6 mice. These findings argue against the Th17/Th1 cell imbalance theory as an explanation for the suppression of CIA in RORγt Tg mice.
Is anti-CII antibody titer important in the development of CIA in RORγt Tg mice? A previous study showed that the development of CIA correlates well with the level of serum anti-CII antibody, particularly the IgG2 subclass . The significantly low level of serum anti-CII total IgG could be one of the causes for the suppression of CIA in RORγt Tg mice, although there was no significant difference in CII-specific IgG2 subclass between the two types of mice. Leavenworth et al.  reported recently that Tfh-dependent autoantibody production results in immune complex formation in joint tissues, and complement activation, and that enhanced intra-articular inflammatory responses induced by Th17 cells play a role in the development of autoimmune arthritis. Tfh cells are known to express CXCR5, ICOS, and PD-1 as superficial markers, and to produce IL-21 for help for B cells [26-28]. In addition, lineage commitment of Tfh cells is directly regulated by transcription factor Bcl-6 . Our results showed lower expression levels of Bcl-6 and IL-21 in CXCR5+CD4+ Tfh cells in RORγt Tg mice than C57BL/6 mice, although the ICOS+PD-1+ Tfh cells increased in draining LNs of RORγt Tg mice, suggesting that the differentiation and the function of Tfh cells might be suppressed in RORγt Tg mice, and which is associated with the reduced anti-CII antibody formation and the suppression of the development of CIA. Although the precise mechanism was not elucidated, the low level of anti-CII antibody might be also related to the diminished ectopic lymphoid follicle formation induced by local synovial inflammation, which is distinct feature of autoimmune arthritis [29,30].
The third possible etiology of arthritis in RORγt Tg mice involves overexpression of RORγt. This scenario is based on the attenuation of CIA in not only RORγt Tg mice but also in C57BL/6 mice with adoptive transfer of CD4+ T cells from RORγt Tg mice. Forkhead family transcription factor Foxp3 is characteristically expressed in a major subset of regulatory T cells . Foxp3+ Treg cells can suppress the activation of Th17 cells and other effector T cell subsets as well as the development of certain autoimmune diseases, including CIA . Interestingly, RORγt expression on Foxp3+ Tregs was significantly upregulated in RORγt Tg mice compared with C57BL/6 mice, although there were no difference between the two groups of mice in Foxp3 expression on CD4+ T cells. Foxp3+ Treg cells also expressed high levels of the co-inhibitory molecule, GITR , produced high amounts of IL-10 but not IL-17, and suppressed the proliferation of effector T cells in RORγt Tg mice. Moreover, the suppression of CIA was partially cancelled by the neutralization of IL-10 in RORγt Tg mice, suggesting that IL-10 produced from Foxp3+ Treg cells might be related to attenuation of CIA in RORγt Tg mice. In addition to our observations, Lochner et al. reported that RORγt+ T cells include pro-inflammatory IL-17-producing Th17 cells and IL-10-producing Foxp3+ Treg cells, and that equilibrium of two types of RORγt+ cells are tightly controlled in vivo . Although the precise mechanism of enhanced suppressive capacity of Foxp3+ Treg cells in RORγt Tg mice was not elucidated, these data support our hypotheses that IL-10-producing RORγt+Foxp3+ Treg cells suppress the development of CIA.
Previous studies report that RORγt can induce the expression of CCR6, which is also known to play a role in arthritogenic Th17 cell recruitment to inflamed joints . Furthermore, CCR6-expressing Treg cells can reduce the Th17-mediated inflammatory response [35,36]. In the present study, RORγt upregulation induced overexpression of CCR6 in Foxp3+ Treg cells, which in turn resulted in preferential migration of Foxp3+ Treg cells in response to CCL20, a ligand of CCR6. Although we have no direct evidence for the involvement of Foxp3+ Treg in the pathogenesis of CIA, the results of previous studies and our findings suggest upregulation of RORγt enhances the expression of CCR6 on Foxp3+ Treg cells, resulting in preferential infiltration of Foxp3+ Treg cells into inflamed joints and suppression of autoimmune synovitis.
Our results suggest that the protective effects of RORγt overexpression against the development of CIA in mice were mediated through the anti-inflammatory effects of intra-articular IL-10-producing CCR6+RORγt+Foxp3+ Treg cells. The results also suggest that modulation of transcription factor expression on CD4+ T cells is a potentially useful therapeutic approach in RA.
B cell lymphoma 6
CC chemokine ligand 20
CC chemokine receptor 6
complementary deoxyribonucleic acid
complete Freund’s adjuvant
carboxyfluorescein diacetate succinimidyl ester
collagen induced arthritis
type II collagen
cytotoxic T-lymphocyte-associated protein 4
CXC chemokine receptor 5
enzyme-linked immunosorbent assay
fluorescence-activated cell sorting
fetal bovine serum
forkhead box P3
GATA binding protein-3
green fluorescent protein
glucocorticoid-induced tumor necrosis factor receptor
inducible T-cell do-stimulator
magnetic-activated cell sorting
mean fluorescence intensity
polymerase chain reaction
programmed cell death-1
- RORγt Tg:
retinoid-related orphan receptor gamma t
standard error of the mean
T-box transcription factor
T follicular helper
transforming growth factor-β
Zhu J, Paul WE. Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors. Immunol Rev. 2010;238:247–62.
Iwanami K, Matsumoto I, Tanaka-Watanabe Y, Inoue A, Mihara M, Ohsugi Y, et al. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase. Arthritis Rheum. 2008;58:754–63.
Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol. 2003;171:6173–7.
Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 2004;50:650–9.
Koenders MI, Lubberts E, Oppers-Walgreen B, van den Bersselaar L, Helsen MM, Di Padova FE, et al. Blocking of inteleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am J Pathol. 2005;167:141–9.
Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, et al. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 1999;42:963–70.
Shen H, Goodall JC, Hill Gaston JS. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 2009;60:1647–56.
Hwang ES, Szabo SJ, Schwartzberg PL, Glimcher LH. T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science. 2005;307:430–3.
Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, et al. TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function. Nature. 2008;453:236–41.
Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000;100:655–69.
Zhang DH, Cohn L, Ray P, Bottomly K, Ray A. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem. 1997;272:21597–603.
Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006;126:1121–33.
Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic inflammation. Nature Rev Drug Discov. 2012;11:763–76.
Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N, et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med. 2007;204:2803–12.
van Hamburg JP, Mus AM, de Bruijn MJ, de Vogel L, Boon L, Comelissen F, et al. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis. Arthritis Rheum. 2009;60:750–9.
Kondo Y, Iizuka M, Wakamatsu E, Yao Z, Tahara M, Tsuboi H, et al. Overexpression of T-bet gene regulates murine autoimmune arthritis. Arthritis Rheum. 2012;64:162–72.
Leipe J, Grunke M, Dechant C, Reindl C, Kerzendorf U, Schulze-Koops H, et al. Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum. 2010;62:2876–85.
Yoh K, Morito N, Ojima M, Shibuya K, Yamashita Y, Morishima Y, et al. Overexpression of RORγt under control of the CD2 promoter induces polyclonal plasmacytosis and autoantibody production in transgenic mice. Eur J Immunol. 2012;42:1–11.
Buttgereit F, Zhou H, Kalak R, Gaber T, Spies CM, Huscher D, et al. Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K/BxN mouse serum-induced arthritis in vivo. Arthritis Rheum. 2009;60:1998–2007.
Cho YG, Cho ML, Min SY, Kim HY. Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis. Autoimmun Rev. 2007;7:65–70.
Ramsdell F. Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity. 2003;19:165–8.
Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol. 2005;6:1142–51.
Chu CQ, Swart D, Alcorn D, Tocker J, Elkon KB. Interferon-γ regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17. Arthritis Rheum. 2007;56:1145–51.
Geboes L, De Klerck B, Van Balen M, Kelchtermans H, Mitera T, Boon L, et al. Freund’s complete adjuvant induces arthritis in mice lacking a functional interferon-γ receptor by triggering tumor necrosis factor α-driven osteoclastogenesis. Arthritis Rheum. 2007;56:2595–607.
Leavenworth JW, Wang X, Wenander CS, Spee P, Cantor H. Mobilization of natural killer cells inhibits development of collagen-induced arthritis. Proc Natl Acad Sci. 2011;108:14584–9.
Glatman Zaretsky A, Taylor JJ, King IL, Marshall FA, Mohrs M, Pearce EJ. T follicular helper cells differentiate from Th2 cells in response to helminth antigens. J Exp Med. 2009;206:991–9.
Chtanova T, Tangye SG, Newton R, Frank N, Hodge MR, Rolph MS, et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol. 2004;173:68–78.
Yu D, Rao S, Tsai LM, Lee SK, He Y, Sutcliffe EL, et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity. 2009;31:457–68.
Takemura S, Braun A, Crowson C, Kurtin PJ, Cofield RH, O’Fallon WM, et al. Lymphoid neogenesis in rheumatoid synovitis. J Immunol. 2001;167:1072–80.
Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356–61.
Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–61.
Ko HJ, Cho ML, Lee SY, Oh HJ, Heo YJ, Moon YM, et al. CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4 + CD25 + Foxp3+ regulatory T cell population. J Autoimmun. 2010;34:111–20.
Uraushihara K, Kanai T, Ko K, Totsuka T, Makita S, Iiyama R, et al. Regulation of murine inflammatory bowel disease by CD25+ and CD25–CD4+ glucocorticoid-induced TNF receptor family-related gene + regulatory T cells. J Immunol. 2003;171:708–16.
Lochner M, Peduto L, Cherrier M, Sawa S, Langa F, Varona R, et al. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORγt + T cells. J Exp Med. 2008;205:1381–93.
Yamazaki T, Yang XO, Chung Y, Fukunaga A, Nurieva R, Pappu B, et al. CCR6 regulates the migration of inflammatory and regulatory cells. J Immunol. 2008;181:8391–401.
Villares R, Cadenas V, Lozano M, Almonacid L, Zaballos A, Martinez-A C, et al. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues. Eur J Immunol. 2009;39:1671–81.
We thank Dr FG Issa for the critical reading of the manuscript. This work was supported by the Research Program for Intractable Diseases, Health and Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare, Japan, and Grants-in Aid for Scientific Research (Grant-in Aid for Young Scientists (B)) from the Ministry of Education, Culture, Sports, Science and Technology and Japan Society for the Promotion of Science.
The authors declare that they have no competing interests.
YK carried out the experiments and statistical analysis, and drafted the manuscript. ZY, MT, MY, and SK assisted in carrying out the experiments and manuscript preparation. MI, SS and HT assisted in data interpretation and manuscript preparation. KY, ST, IM, and TS conceived of the study, participated in its design and coordination, and helped to draft the manuscripts. All authors read and approved the final manuscript.